Company Filing History:
1 out of 11 
1 out of 5,094 
Years Active: 2012
Title: Malgorzata Rak: Innovator in Mitochondrial Research
Introduction
Malgorzata Rak is a notable inventor based in Checiny, Poland. She has made significant contributions to the field of mitochondrial research, particularly in relation to NARP syndrome. Her innovative work has led to the development of a patent that addresses critical health issues associated with mitochondrial deficiencies.
Latest Patents
Malgorzata Rak holds a patent for "Modified yeast cells comprising at least one mutation of the tryptophan 136 (W), leucine 183 (L), or leucine 247 (L) codon of the mitochondrial ATP6 gene, responsible for NARP syndrome in humans and uses thereof for screening for medicaments that act against mitochondrial pathologies involving a deficiency in ATP production via the oxidative phosphorylation pathway, such as NARP syndrome." This patent highlights her dedication to advancing medical science and finding solutions for complex health challenges.
Career Highlights
Throughout her career, Malgorzata has worked with esteemed institutions such as Université Victor Segalen—Bordeaux 2 and the Centre National de la Recherche Scientifique. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Malgorzata has collaborated with notable colleagues, including Jean-Paul Di Rago and Roza Kucharczyk. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Malgorzata Rak's contributions to mitochondrial research and her innovative patent demonstrate her commitment to addressing significant health issues. Her work continues to inspire advancements in medical science and offers hope for those affected by mitochondrial pathologies.